These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 325780)

  • 1. Four patterns of human renal allograft rejection: a cytologic and in vitro analysis of the infiltrate in 24 irreversibly rejected kidneys.
    Busch GJ; Schamberg JF; Moretz RC; Strom TB; Tilney NL; Carpenter CB
    Transplant Proc; 1977 Mar; 9(1):37-42. PubMed ID: 325780
    [No Abstract]   [Full Text] [Related]  

  • 2. T and B cell patterns in irreversibly rejected human renal allografts. Correlation of morphology with surface markers and cytotoxic capacity of the isolated lymphoid infiltrates.
    Busch GJ; Schamberg JF; Moretz RC; Strom TB; Tilney NL; Carpenter CB
    Lab Invest; 1976 Sep; 35(3):272-80. PubMed ID: 785094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection.
    Wagrowska-Danilewicz M; Danilewicz M
    Nefrologia; 2003; 23(6):538-44. PubMed ID: 15002789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of B lymphocytes (CD20+) in renal allograft biopsy specimens.
    Martins HL; Silva C; Martini D; Noronha IL
    Transplant Proc; 2007 Mar; 39(2):432-4. PubMed ID: 17362749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active T and EA-rosette-forming cells in human cadaver renal allograft recipients.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1979 Feb; 35(2):236-41. PubMed ID: 373936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of pretransplant antibodies on early renal allograft rejection.
    Alarif L; Rodriguez R; Blackburn S; Light JA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):771-2. PubMed ID: 3274869
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo - in vitro correlates of antithymocyte globulin (ATG) immunosuppression in the human.
    Thomas F; Berry R; Mendez-Picon G; Thomas J; Lower RR; Lee HM
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():56-61. PubMed ID: 386321
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-Ia antibody eluted from rejected human renal allografts.
    Garovoy MR; Suthanthiran M; Gailiunas P; Carpenter CB; Graves M; Busch G; Tilney NL
    Transplant Proc; 1978 Sep; 10(3):613-6. PubMed ID: 362645
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms in organ allograft rejection. An experimental and clinical study.
    Claesson K
    Scand J Urol Nephrol Suppl; 1987; 103():1-42. PubMed ID: 3321417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute cellular kidney allograft rejection with T10B9.1A-31A anti T-cell monoclonal antibody.
    Waid TH; Lucas BA; Thompson JS; Brown S; Moore D; Amlot P; Janossy G
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1778-84. PubMed ID: 2652582
    [No Abstract]   [Full Text] [Related]  

  • 11. T11+/DR+ lymphocytes in renal allograft recipients with irreversible rejection.
    Hayes JM; Valenzuela R; Novick AC; Steinmuller DR
    Transplantation; 1988 Apr; 45(4):806-9. PubMed ID: 2895969
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization and alterations of lymphocyte subpopulations in renal allograft recipients.
    Chatterjee SN; Gershwin ME; Eckles D
    Transplant Proc; 1979 Mar; 11(1):374-8. PubMed ID: 377659
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prognostic significance of antilymphocyte antibodies in a perivital kidney allograft].
    Savchenko NE; Levin VI; Buglova SE; Chashinskaia TI
    Urol Nefrol (Mosk); 1984; (4):3-6. PubMed ID: 6382734
    [No Abstract]   [Full Text] [Related]  

  • 14. Retrospective analysis of T and B cells flow-cross matches in renal transplant recipients.
    C LK; Kamaraju SR; Kancherla R
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):571-3. PubMed ID: 18580015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotoxin mediated killing of clonable T-lymphocytes infiltrating an irreversibly rejected human renal allograft.
    Siena S; Bregni M; Formosa A; Brando B; Lappi DA; Bonadonna G; Gianni AM
    J Biol Regul Homeost Agents; 1989; 3(2):84-8. PubMed ID: 2479229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies eluted from rejected human renal allografts: specificity to B lymphocytes, monocytes, primary kidney cells, and endothelial cells.
    Lee HM; Waldrep JC; Mendez-Picon G; Mohanakumar T
    Transplant Proc; 1981 Mar; 13(1 Pt 1):108-10. PubMed ID: 7022806
    [No Abstract]   [Full Text] [Related]  

  • 17. Tubulitis in renal allograft rejection: role of transforming growth factor-beta and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells.
    Wong WK; Robertson H; Carroll HP; Ali S; Kirby JA
    Transplantation; 2003 Feb; 75(4):505-14. PubMed ID: 12605119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes.
    Majoor GD; Van Breda Vriesman PJ
    Transplantation; 1983 Feb; 35(2):121-6. PubMed ID: 6338632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [T- and B-lymphocytes in patients with chronic renal failure and in recipients of cadaveric allokidneys during the immediate posttransplant period].
    Dzerzhinskaia II
    Biull Eksp Biol Med; 1979 Feb; 87(2):174-6. PubMed ID: 369635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection.
    Mayer TG; Fuller AA; Fuller TC; Lazarovits AI; Boyle LA; Kurnick JT
    J Immunol; 1985 Jan; 134(1):258-64. PubMed ID: 3155462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.